Hydrophilic/Hydrophobic Patterned α-Hydroxy Acid Oligomers
ether/pentane, 4:1) to yield 8 (mixture of diastereoisomers; 2.04 g,
6.50 mmol, 64%) as a colorless oil. Rf = 0.78 (diethyl ether/pentane,
pTosOH in methanol (1 mgmL–1) and the reaction mixture was
stirred at room temperature for 1.25 h. The crude product was puri-
4:1). 1H NMR (400 MHz, CDCl3): δ = 5.94–5.75 (m, 1 H, fied by silica gel column chromatography (diethyl ether/pentane,
CH=CH2), 5.19–5.08 (m, 3 H, CH=CH2, CH-COOH), 4.75–4.58 1:4) to give 12 (405.5 mg, 0.84 mmol, 94%) as a colorless oil. Rf =
[m, 1 H, O-CH(CH2)-O], 4.44–4.41 and 4.12–4.09 [m, 1 H, O- 0.29 (diethyl ether/pentane, 1:4). 1H NMR (400 MHz, CDCl3): δ =
CH(CH2)-CO], 3.96–3.81 and 3.52–3.40 (m, 2 H, CH2-CH2-O),
2.66–2.50 (m, 2 H, CH-CH2-CH), 1.86–1.49 [m, 9 H, (CH2)3, CH2- CH(CH2)-CO], 4.65–4.64 (m, 2 H, O-CH2-CH), 4.36–4.32 (m, 1 H,
CH-(CH3)2]; 0.96–0.91 (m, 6 H, CH3) ppm. 13C NMR (100 MHz,
OH-CH), 2.80–2.54 (m, 4 H, CH-CH2-CH), 1.91–1.64 [m, 6 H,
CDCl3): δ = 175.58, 171.93, 133.23, 118.07, 97.11, 73.33, 70.67, CH2-CH-(CH3)2], 0.99–0.94 (m, 12 H, CH3) ppm. 13C NMR
5.95–5.81 (m, 3 H, CH=CH2), 5.37–5.13 [m, 9 H, CH=CH2, O-
62.15, 39.51, 37.10, 30.15, 25.35, 24.59, 22.94, 21.40, 18.83 ppm.
ESI-MS: m/z: calcd. for C16H26O6 + Na+: 337.1627; found
337.1631.
(100 MHz, CDCl3): δ = 173.95, 169.62, 169.44, 168.66, 132.38,
131.42, 131.35, 119.15, 119.06, 118.97, 71.93, 71.72, 71.46, 69.66,
65.96, 39.59, 39.39, 38.75, 35.10, 24.54, 24.52, 22.96, 22.92, 21.47,
21.39 ppm. ESI-MS: m/z: calcd. for C25H38O9 + Na+: 505.2414;
found 505.2428.
Allyl Ester-Protected Dimer 9: According to GP3, 7 (3.55 g,
10 mmol) was treated with 133 mL of a solution of pTosOH in
methanol (1 mgmL–1) and the reaction mixture was stirred at room
temperature for 3 h. The crude product was purified by silica gel
column chromatography (diethyl ether/pentane, 1:4) to give 9
(1.98 g, 7.32 mmol, 73%) as a colorless oil. Rf = 0.37 (diethyl ether/
pentane, 1:4). 1H NMR (400 MHz, CDCl3): δ = 5.98–5.82 (m, 2
H, CH=CH2), 5.37–5.16 [m, 5 H, CH=CH2, O-CH(CH2)-CO],
4.66–4.63 (m, 2 H, O-CH2-CH), 4.35–4.32 (m, 1 H, OH-CH), 2.69–
2.53 (m, 2 H, CH-CH2-CH), 1.86–1.69 [m, 3 H, CH2-CH-(CH3)2],
0.98–0.94 (m, 6 H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ =
173.98, 169.69, 132.36, 131.31, 119.07, 118.99, 71.74, 69.64, 65.96,
39.63, 38.72, 24.55, 22.92, 21.42 ppm. ESI-MS: m/z: calcd. for
C14H22O5 + H+: 271.1545; found 271.1575.
Double-Protected Octamer 13: According to GP1, 11 (232.4 mg,
0.44 mmol) and 12 (205.9 mg, 0.43 mmol) were reacted in the pres-
ence of DMAP (2.9 mg, 0.024 mmol) and DCC (123 mg, 0.6 mmol)
in CH2Cl2 (5 mL) for 2.5 h at 0 °C. Purification by silica gel column
chromatography (diethyl ether/pentane, 1:4) yielded 13 (mixture of
diastereoisomers; 345.6 mg, 0.35 mmol, 82%) as a colorless oil. Rf
1
= 0.61 (diethyl ether/pentane, 1:4). H NMR (400 MHz, CDCl3): δ
= 5.93–5.76 (m, 5 H, CH=CH2), 5.32–5.08 (m, 17 H, CH=CH2,
CO-O-CH), 4.74–4.61 [m, 3 H, O-CH2-CH, O-CH(CH2)-O], 4.43–
4.39 and 4.12–4.09 [m, 1 H, O-CH(CH2)-CO], 3.90–3.80 and 3.50–
3.38 (m, 2 H, CH2-CH2-O), 2.73–2.49 (m, 8 H, CH2=CH-CH2),
1.84–1.49 [m, 18 H, CH-(CH2)3-CH2, (CH3)2-CH-CH2], 0.95–0.90
(m, 24 H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.95,
169.78, 169.59, 169.56, 169.34, 169.31, 168.67, 168.59, 133.34,
133.05, 131.45, 131.37, 131.33, 118.99, 118.95, 118.90, 118.03,
117.93, 96.97, 76.20, 73.22, 71.87, 71.74, 71.64, 71.30, 70.77, 70.53,
65.89, 61.99, 39.55, 39.42, 39.34, 39.31, 37.13, 36.87, 35.03, 34.85,
30.15, 25.39, 24.50, 24.48, 24.46, 24.43, 22.95, 22.93, 22.92, 22.88,
21.42, 21.34, 21.35, 21.28, 18.79 ppm. ESI-MS: m/z: calcd. for
C52H78O18 + Na+: 1013.5086; found 1013.5056.
Double-Protected Tetramer 10: According to GP1, 8 (2.66 g,
8.45 mmol) and 9 (2.08 g, 7.68 mmol) were reacted in the presence
of DMAP (95.7 mg, 0.78 mmol) and DCC (2.23 g, 10.83 mmol) in
CH2Cl2 (25 mL) for 2 h. Purification by silica gel column
chromatography (diethyl ether/pentane, 1:4) yielded 10 (mixture of
diastereoisomers; 3.22 g, 5.68 mmol, 74%) as a colorless oil. Rf =
0.71 (diethyl ether/pentane, 1:4). 1H NMR (400 MHz, CDCl3): δ =
5.94–5.75 (m, 3 H, CH=CH2), 5.32–5.06 (m, 9 H, CH=CH2, CO-
O-CH), 4.75–4.59 [m, 3 H, O-CH2-CH, O-CH(CH2)-O], 4.42–4.39
and 4.12–4.09 [m, 1 H, O-CH(CH2)-CO], 3.90–3.80 and 3.49–3.38
(m, 2 H, CH2-CH2-O), 2.75–2.45 (m, 4 H, CH2=CH-CH2), 1.87–
1.48 [m, 12 H, CH-(CH2)3-CH2, (CH3)2-CH-CH2], 0.95–0.90 (m,
12 H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.98, 169.79,
169.62, 168.71, 133.37, 133.07, 131.46, 118.91, 118.04, 117.94,
96.99, 73.24, 71.65, 70.80, 70.56, 65.90, 62.02, 39.59, 39.37, 37.16,
35.09, 30.10, 25.37, 24.51, 22.90, 21.46, 18.81 ppm. ESI-MS: m/z:
calcd. for C30H46O10 + Na+: 589.2989; found 589.3011.
(9S,12S)-12-Hydroxy-9-isobutyl-8,11-dioxo-7,10-dioxa-3,16-dithia-
octadecane-1,18-dioic Acid (14): The synthesis of this compound
was optimized in a number of reactions, which are summarized in
Table 2. The following protocol describes the optimal conditions
(Entry 5 in Table 2). According to GP4, 7 (35.4 mg, 0.1 mmol,
0.2 mmol allyl groups) was treated with AIBN (10.8 mg,
0.066 mmol) and thioglycolic acid (138.9 µL, 2 mmol) in 4 mL of
toluene at 70 °C for 18 h. The reaction product was then evapo-
rated to dryness, dissolved in CH2Cl2 and washed twice with a
saturated solution of NaCl. The organic phase was dried with
MgSO4, concentrated under reduced pressure and dried under high
vacuum to give 14 (42.1 mg, 0.093 mmol, 92.7%) as a light yellow
oil. 1H NMR (400 MHz, CDCl3): δ = 5.10–4.97 (m, 2 H, CH-CO),
4.23–4.15 (m, 2 H, O-CH2), 3.20 (s, 4 H, CH2-COOH), 2.67–2.64
(m, 4 H, CH2-S), 1.95–1.49 [m, 9 H, CH2-CH-(CH3)2, O-CH2-CH2,
CH-(CH2)2], 0.91–0.79 (m, 6 H, CH3) ppm. 13C NMR (100 MHz,
CDCl3): δ = 176.19, 175.80, 174.62, 170.01, 71.97, 69.90, 63.83,
39.48, 33.37, 33.12, 33.00, 31.85, 30.48, 28.86, 25.26, 24.52, 22.86,
21.45 ppm. ESI-MS: m/z: calcd. for C18H30O9S2 + H+: 455.1410;
found 455.1394.
THP-Protected Tetramer 11: According to GP2, 10 (504.7 mg,
0.89 mmol) was treated with Pd(PPh3)4 (102.8 mg, 0.09 mmol) and
morpholine (79.7 mg, 0.91 mmol) at 0 °C in 15 mL of THF for 1 h.
The crude product was purified by silica gel column chromatog-
raphy (diethyl ether/pentane, 4:1) to yield 11 (mixture of diastereo-
isomers; 311.4 mg, 0.59 mmol, 66%) as a colorless oil. Rf = 0.54
(diethyl ether/pentane, 4:1). 1H NMR (400 MHz, CDCl3): δ = 5.95–
5.76 (m, 2 H, CH=CH2), 5.19–5.09 (m, 7 H, CH=CH2, CO-O-CH),
4.75–4.68 [m, 1 H, O-CH(CH2)-O], 4.43–4.40 and 4.14–4.12 [m, 1
H, O-CH(CH2)-CO], 3.86–3.84 and 3.51–3.39 (m, 2 H, CH2-CH2-
O), 2.73–2.52 (m, 4 H, CH-CH2-CH), 1.82–1.52 [m, 12 H,
(CH2)3, CH2-CH-(CH3)2], 0.96–0.91 (m, 12 H, CH3) ppm. 13C
NMR (100 MHz, CDCl3): δ = 174.86, 172.08, 169.72, 168.70,
133.35, 131.33, 119.11, 118.03, 97.05, 73.30, 71.78, 71.18, 70.89,
62.08, 39.47, 39.40, 37.18, 35.06, 30.19, 25.37, 24.56, 22.90, 21.43,
18.80 ppm. ESI-MS: m/z: calcd. for C27H42O10 + Na+: 549.2676;
found 549.2651.
3-[(2-Hydroxyethyl)thio]propyl (2S)-2-{[(2S)-5-[(2-Hydroxyethyl)-
thio]-2-(tetrahydro-2H-pyran-2-yloxy)pentanoyl]oxy}-4-methylpen-
tanoate (15): The synthesis of this compound was optimized in a
number of reactions, which are summarized in Table 2. The follow-
ing protocol corresponds to the optimized conditions (Entry 10 in
Table 2). According to GP4, 7 (35.2 mg, 0.1 mmol, 0.2 mmol allyl
groups) was treated with AIBN (10.8 mg, 0.066 mmol) and mercap-
toethanol (140.6 µL, 2 mmol) in 4 mL of toluene at 70 °C for 18 h.
Allyl Ester-Protected Tetramer 12: According to GP3, 10
(504.3 mg, 0.89 mmol) was treated with 9 mL of a solution of
Eur. J. Org. Chem. 2009, 5390–5405
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5403